The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer

Background The concomitant use of tyrosine kinase inhibitors (TKIs) and proton pump inhibitors (PPIs) is a significant concern because of potential drug‐drug interaction that reduces TKI absorption, thus potentially reducing the effectiveness of TKIs. The objective of this study was to evaluate the...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 125; no. 7; pp. 1155 - 1162
Main Authors Sharma, Manvi, Holmes, Holly M., Mehta, Hemalkumar B., Chen, Hua, Aparasu, Rajender R., Shih, Ya‐Chen T., Giordano, Sharon H., Johnson, Michael L.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2019
Subjects
Online AccessGet full text

Cover

Loading…